Opinion
Video
Newer Combinations for the Treatment of CLL
Dr Linhares discusses newer combination therapies for the treatment of patients with chronic lymphocytic leukemia, highlighting ibrutinib and venetoclax, which is being studied in the CAPTIVATE trial.
EP: 1.Understanding a CLL Diagnosis
EP: 2.Diagnostic Tests in CLL
EP: 3.Goals of Treatment for Patients With CLL
EP: 4.Current First-Line Treatment Options in CLL
EP: 5.Factors That Guide CLL Treatment Decisions
EP: 6.What to Expect from Treatment
EP: 7.Overview of Efficacy and Safety Data for Current CLL Treatment Options
EP: 8.Acalabrutinib-Based Treatment Clinical Trial Updates
EP: 9.Venetoclax-Based Treatment Clinical Trial Updates
EP: 10.Zanubrutinib-Based Treatment Clinical Trial Updates
EP: 11.Ibrutinib-Based Treatment Clinical Trial Updates
Now Viewing
EP: 12.Newer Combinations for the Treatment of CLL
EP: 13.What to Know Before Starting Your CLL Treatment
EP: 14.An Overview of Potential Treatment Adverse Effects
EP: 15.Treatment Decisions in R/R CLL
EP: 16.Shared Decision-Making and Supportive Care in the CLL Treatment Journey
EP: 17.Optimizing Overall Health During CLL Management
EP: 18.Getting the Most From Your CLL Care Team
Related Videos
Related Content
